Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
Samar El‐Kalyoubi, Mohamed M. Khalifa, Mahmoud T. Abo‐Elfadl, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Selenium-copper hyaluronic acid nanoparticles: A novel green synthesis for improved anticancer activity against HepG2 liver cancer cells
Mohammad Fazel Vafadar, Yasin Ghabool, Kimia Ahmadi, et al.
Inorganic Chemistry Communications (2025) Vol. 173, pp. 113869-113869
Closed Access
New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
Ulviye Acar Çevik, Betül Kaya, İsmail Çeli̇k, et al.
ACS Omega (2024)
Open Access | Times Cited: 5
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical Assessments
Ahmed A. Al‐Karmalawy, Mai H. A. Mousa, Marwa Sharaky, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 492-512
Closed Access | Times Cited: 13
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy
Norhan A. Abdelrahman, Ahmed A. Al‐Karmalawy, Maiy Jaballah, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 981-997
Closed Access | Times Cited: 3
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations
Haytham O. Tawfik, Mai H. A. Mousa, Mohamed Y. Zaky, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107483-107483
Closed Access | Times Cited: 3
Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations
Saad Shaaban, Hanan A. Althikrallah, Amr Negm, et al.
RSC Advances (2024) Vol. 14, Iss. 26, pp. 18576-18587
Open Access | Times Cited: 3
Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays
Faten Farouk, Ibrahim M. Ibrahim, Salma Sherif, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 2
Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment
Marwa Abdel‐Motaal, Dalal Ali Aldakhili, Ayman Abo Elmaaty, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Closed Access | Times Cited: 2
Anticancer effect of spirooxindole derivatives
Neeraj Kumar Chouhan, Mamta N. Talati, Mani Sharma, et al.
Elsevier eBooks (2024), pp. 587-604
Closed Access | Times Cited: 2
Design and Synthesis of Novel Pyrazolopyrimidine Candidates As Promising EGFR-T790M Inhibitors and Apoptosis Inducers
Ahmed A. Abdel Gaber, Marwa Sharaky, Ayman Abo Elmaaty, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1773-1790
Open Access | Times Cited: 6
Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR‐2 Inhibitors and Endowed with Apoptotic Potential
Norhan Eid, Ahmed A. Al‐Karmalawy, Taha M. A. Eldebss, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 1
Rational design and eco-friendly one-pot multicomponent synthesis of novel ethylidenehydrazineylthiazol-4(5H)-ones as potential apoptotic inducers targeting wild and mutant EGFR-TK in triple negative breast cancer
Eslam M. Abbass, Ahmed A. Al‐Karmalawy, Marwa Sharaky, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106936-106936
Closed Access | Times Cited: 5
Synthesis, In-Vitro, In-Vivo screening, and molecular docking of disubstituted aminothiazole derivatives and their selenium nanoparticles as potential antiparkinson agents
Lamiaa O. El-Halaby, Nada F. Abo El‐Magd, Samar J. Almehmadi, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138951-138951
Closed Access | Times Cited: 1
Spirooxindole derivatives as an anticancer agent
Ihab Shawish, Abdullah Mohammed Al‐Majid, Assem Barakat
Elsevier eBooks (2024), pp. 411-438
Closed Access
Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; Synthesis, evaluation, and molecular modelling studies
Mohammad Shahidul Islam, Refaah Mousa Al‐Jassas, Abdullah Mohammed Al‐Majid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2937-2958
Closed Access
Design and Synthesis of Novel Multi-Target Tetrabromophthalimides as CBS, Topo-II Inhibitors, and DNA Intercalators
Marwa Abdel‐Motaal, Dalal Ali Aldakhili, Ayman Farag, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Page 1

Scroll to top